STOCK TITAN

State Street (NTLA) stake: 9.23M Intellia Therapeutics shares in 13G filing

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Intellia Therapeutics, Inc. (NTLA) reports that State Street Corporation has filed as an institutional holder of its common stock. State Street reports 9,234,987 shares beneficially owned, representing 6.8% of the outstanding common stock as of the reporting date. It has shared voting power over 8,907,136 shares and shared dispositive power over 9,234,987 shares, with no sole voting or dispositive power. The holding is reported on behalf of State Street and certain investment advisory subsidiaries, including SSGA Funds Management, Inc. and State Street Global Advisors entities.

Positive

  • None.

Negative

  • None.
Beneficial ownership 9,234,987 shares Shares of Intellia Therapeutics common stock reported as beneficially owned by State Street Corporation
Percent of class 6.8% Percentage of Intellia Therapeutics common stock class beneficially owned by State Street Corporation
Shared voting power 8,907,136 shares Shares over which State Street has shared power to vote or direct the vote
Shared dispositive power 9,234,987 shares Shares over which State Street has shared power to dispose or direct disposition
Sole voting power 0 shares Shares over which State Street has sole power to vote or direct the vote
Sole dispositive power 0 shares Shares over which State Street has sole power to dispose or direct disposition
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 9234987.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"(ii) Shared power to vote or to direct the vote: 8,907,136"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"(iv) Shared power to dispose or to direct the disposition of: 9,234,987"
Schedule 13G regulatory
"If a parent holding company has filed this schedule, pursuant to (ii)(G)"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What percentage of Intellia Therapeutics (NTLA) shares does State Street Corporation report holding?

State Street Corporation reports beneficial ownership of 6.8% of Intellia Therapeutics’ common stock, representing 9,234,987 shares as disclosed in the Schedule 13G filing for the company.

How many Intellia Therapeutics (NTLA) shares does State Street Corporation beneficially own?

State Street Corporation reports 9,234,987 shares beneficially owned of Intellia Therapeutics common stock, corresponding to 6.8% of the class, according to the ownership details in the Schedule 13G filing.

What voting power does State Street have over Intellia Therapeutics (NTLA) shares?

State Street reports shared voting power over 8,907,136 shares of Intellia Therapeutics common stock and no sole voting power, indicating voting authority is exercised jointly, typically through its advisory subsidiaries.

What dispositive power does State Street hold over Intellia Therapeutics (NTLA) stock?

State Street reports shared dispositive power over 9,234,987 shares of Intellia Therapeutics and no sole dispositive power, meaning decisions to sell or otherwise dispose are held on a shared basis.

Which State Street subsidiaries are associated with the Intellia Therapeutics (NTLA) holdings?

The filing associates the holdings with SSGA Funds Management, Inc. and several State Street Global Advisors entities, including Europe Limited, Limited, Trust Company, and Ltd., each classified as investment advisers (IA).





45826J105

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



STATE STREET CORPORATION
Signature:ELIZABETH SCHAEFER
Name/Title:SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER
Date:08/07/2026